Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagaa catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
BD318446.1 | emblrelpat | WO 2003048363-A/18: C-terminal modi... | 5172 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OL312704.1 | nt | Cloning vector pDmAct5C::Cas9-2A-Ne... | 10283 bp | Cloning vector pDmAct5C::Cas9-2A-Neo | QL-ELE-00-002 | 215 bp | View |
OL312705.1 | nt | Cloning vector pAaePUb::Cas9-2A-Neo... | 8802 bp | Cloning vector pAaePUb::Cas9-2A-Neo | QL-ELE-00-002 | 215 bp | View |
JC171600.1 | emblrelpat | Sequence 53 from Patent WO2013149167. | 9020 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LZ996119.1 | emblrelpat | JP 2017532045-A/2: COMPOSITIONS OF ... | 4278 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MH212166.1 | nt | Expression vector pCMV-NP868R, comp... | 6757 bp | Expression vector pCMV-NP868R | QL-ELE-00-002 | 215 bp | View |
DI240840.1 | emblrelpat | KR 1020120050480-A/102: ANTIBODIES ... | 5432 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
DI350504.1 | emblrelpat | KR 1020130111212-A/102: ANTI-HUMAN ... | 5432 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
MK521430.1 | nt | Cloning vector pHREAC-EV, complete ... | 10507 bp | Cloning vector pHREAC-EV | QL-ELE-00-002 | 215 bp | View |
DI350513.1 | emblrelpat | KR 1020130111212-A/391: ANTI-HUMAN ... | 6822 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
FB506764.1 | emblrelpat | Sequence 4 from Patent WO2008095927. | 2481 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
GN078819.1 | emblrelpat | Sequence 5 from Patent EP2037270. | 4196 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MX629288.1 | emblrelpat | Sequence 53 from patent US 10993999. | 9020 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
AR403986.1 | emblrelpat | Sequence 40 from patent US 6627436. | 5532 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
BD284966.1 | emblrelpat | WO 2003014734-A/1: Method for detec... | 5172 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
EA263973.1 | emblrelpat | Sequence 30 from patent US 7238478. | 4533 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
GV657879.1 | emblrelpat | Sequence 168 from patent US 7670787. | 5172 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HW103755.1 | emblrelpat | JP 2013501527-A/93: ANTIBODIES AGAI... | 6822 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
HJ560355.1 | emblrelpat | Sequence 18 from patent US 8598328. | 1800 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_FB704342 | nrnl1 | Sequence 24 from Patent WO200700358... | 4920 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.